APUS

Apimeds Pharmaceuticals US, Inc.

Price Chart

Latest Quote

$1.27

-0.14 (-9.93%)

Current Price

Previous Close	$1.41
Open	$1.44
Day High	$1.44
Day Low	$1.25
Volume	20,018

Fetched: 2026-06-05T22:20:05

Stock Information

Shares Outstanding	15.09M
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Market Cap	$19.17M
EPS (TTM)	$-2.78
Exchange	ASE

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Book/sh

$0.65

Financial Ratios

Returns & Margins

Ownership

Insider Ownership	44.55%
Institutional Ownership	2.97%
Insider & Institutional transactions data not available

Valuation Ratios

P/B

1.96

Analyst Data

Recommendation

none

Technical Indicators

SMA20	$1.41
SMA50	$1.70
SMA200	$14.60
RSI	37.50
ATR	0.1572

Short Float	3.39%
Short Ratio	0.60
Rel Volume	0.37

Performance History

Week	-9.93%
Month	-34.87%
Quarter	-90.45%
6 Months	-94.17%
YTD	-92.37%
Year	-93.24%
10 Years	-94.23%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-05	$1.27	20,300
2026-06-04	$1.41	57,800
2026-06-03	$1.35	68,200
2026-06-02	$1.32	25,500
2026-06-01	$1.52	30,900
2026-05-29	$1.41	13,400
2026-05-28	$1.36	43,300
2026-05-27	$1.42	59,500
2026-05-26	$1.42	34,100
2026-05-22	$1.50	41,400
2026-05-21	$1.40	21,300
2026-05-20	$1.39	25,000
2026-05-19	$1.42	20,400
2026-05-18	$1.49	36,100
2026-05-15	$1.51	69,500
2026-05-14	$1.37	109,900
2026-05-13	$1.30	50,300
2026-05-12	$1.34	21,100
2026-05-11	$1.46	163,300
2026-05-08	$1.51	175,400
2026-05-07	$1.45	569,500
2026-05-06	$1.95	806,300

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

📰 Latest News

No news articles available at the moment. Check back later for updates on APUS.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Interest Expense	$283,011	$117,719	$38,069	$29,137
Total Expenses	$11,912,562	$1,275,095	$747,436	$639,529
Other Income Expense	$6,086,841	-	-	-
Other Non Operating Income Expenses	$97	-	-	-
Net Non Operating Interest Income Expense	$-175,416	$-114,895	$-30,258	$-29,137
Interest Expense Non Operating	$283,011	$117,719	$38,069	$29,137
Operating Expense	$11,912,562	$1,275,095	$747,436	$639,529
General And Administrative Expense	$10,279,981	$1,275,095	$648,892	$271,529
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Net Interest Income	$-175,416	$-114,895	$-30,258	$-29,137
Interest Income	$107,595	$2,824	$7,811	$0
Normalized Income	$-12,087,881	$-1,389,990	$-777,694	$-668,666
Net Income From Continuing And Discontinued Operation	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Total Operating Income As Reported	$-11,912,562	$-1,275,095	$-747,436	$-639,529
Net Income Common Stockholders	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Net Income	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Net Income Including Noncontrolling Interests	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Net Income Continuous Operations	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Pretax Income	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Interest Income Non Operating	$107,595	$2,824	$7,811	$0
Operating Income	$-11,912,562	$-1,275,095	$-747,436	$-639,529
Per Share
Diluted EPS	$-0.55	$-0.12	$-0.07	$-0.06
Basic EPS	$-0.55	$-0.12	$-0.07	$-0.06
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-11,799,164	$-1,272,271	$-739,625	$-639,529
Total Unusual Items	$6,086,744	-	-	-
Total Unusual Items Excluding Goodwill	$6,086,744	-	-	-
Reconciled Depreciation	$5,706	$0	-	-
EBITDA (Bullshit earnings)	$-5,712,420	$-1,272,271	$-739,625	$-639,529
EBIT	$-5,718,126	$-1,272,271	$-739,625	$-639,529
Diluted Average Shares	$10,881,907	$11,571,497	$11,571,497	$11,571,497
Basic Average Shares	$10,881,907	$11,571,497	$11,571,497	$11,571,497
Diluted NI Availto Com Stockholders	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Gain On Sale Of Security	$6,086,744	-	-	-
Research And Development	$1,632,581	$0	$98,544	$368,000
Selling General And Administration	$10,279,981	$1,275,095	$648,892	$271,529
Other Gand A	$10,279,981	$1,275,095	$534,892	$48,123
Salaries And Wages	-	$413,404	$114,000	$223,406

Fetched: 2026-06-05

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$153,347,827	$-1,358,121	$31,869	$-713,606
Total Assets	$164,183,736	$13,057	$422,076	$6,171
Total Non Current Assets	$150,199,877	$0	$0	$0
Non Current Prepaid Assets	$75,485	$0	-	-
Current Assets	$13,983,859	$13,057	$422,076	$6,171
Other Current Assets	$48,500	$9,602	$11,595	-
Restricted Cash	$8,000,000	-	-	-
Prepaid Assets	$2,298,704	$9,602	$11,595	$0
Cash Cash Equivalents And Short Term Investments	$3,636,655	$3,455	$410,481	$6,171
Cash And Cash Equivalents	$1,636,655	$3,455	$410,481	$6,171
Cash Financial	$1,636,655	$3,455	$410,481	$6,171
Debt
Net Debt	$5,954,708	$593,389	-	$653,829
Total Debt	$7,760,395	$596,844	$266,891	$660,000
Long Term Debt And Capital Lease Obligation	$129,454	$346,844	$266,891	$400,000
Current Debt And Capital Lease Obligation	$7,630,941	$250,000	-	$260,000
Current Debt	$7,591,363	$250,000	-	$260,000
Other Current Borrowings	$7,091,263	$250,000	-	$260,000
Long Term Debt	-	$346,844	$266,891	$400,000
Liabilities
Total Liabilities Net Minority Interest	$10,835,909	$1,371,178	$390,207	$719,777
Total Non Current Liabilities Net Minority Interest	$129,454	$346,844	$266,891	$400,000
Current Liabilities	$10,706,455	$1,024,334	$123,316	$319,777
Other Current Liabilities	$1,616,913	-	-	-
Current Notes Payable	$500,100	$250,000	$0	$260,000
Payables And Accrued Expenses	$1,458,601	$774,334	$123,316	$59,777
Interest Payable	$27,952	$106,643	$68,878	$35,877
Payables	$930,649	$667,691	$54,438	$23,900
Accounts Payable	$918,649	$591,191	-	$36,877
Other Payable	-	$410,641	$54,438	-
Total Tax Payable	-	-	$0	$1,000
Equity
Common Stock Equity	$153,273,057	$-1,358,121	$31,869	$-713,606
Preferred Stock Equity	$74,770	-	-	-
Total Equity Gross Minority Interest	$153,347,827	$-1,358,121	$31,869	$-713,606
Stockholders Equity	$153,347,827	$-1,358,121	$31,869	$-713,606
Retained Earnings	$-10,393,061	$-4,391,924	$-3,001,934	$-2,224,240
Other
Ordinary Shares Number	$12,575,983	$11,571,497	$11,571,497	$11,571,497
Share Issued	$12,575,983	$11,571,497	$11,571,497	$11,571,497
Tangible Book Value	$153,273,057	$-1,358,121	$31,869	$-713,606
Invested Capital	$160,864,420	$-761,277	$298,760	$-53,606
Working Capital	$3,277,404	$-1,011,277	$298,760	$-313,606
Capital Lease Obligations	$169,032	$0	-	-
Total Capitalization	$153,347,827	$-1,011,277	$298,760	$-313,606
Additional Paid In Capital	$163,540,358	$2,954,764	$2,954,764	$1,410,634
Capital Stock	$200,530	$79,039	$79,039	$100,000
Common Stock	$125,760	$79,039	$79,039	$100,000
Preferred Stock	$74,770	$0	$0	$0
Long Term Capital Lease Obligation	$129,454	$0	-	-
Current Capital Lease Obligation	$39,578	$0	-	-
Current Accrued Expenses	$527,952	$106,643	$68,878	$35,877
Dueto Related Parties Current	$12,000	$76,500	$0	$22,900
Investments And Advances	$149,885,371	$0	-	-
Other Investments	$149,885,371	$0	-	-
Net PPE	$239,021	$0	-	-
Gross PPE	$239,021	$0	-	-
Other Properties	$239,021	-	-	-
Other Short Term Investments	$2,000,000	-	-	-
Pensionand Other Post Retirement Benefit Plans Current	-	$180,550	$0	-

Fetched: 2026-06-05

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-8,983,110	$-733,526	$-627,790	$-448,167
Operating Activities
Operating Cash Flow	$-8,925,777	$-733,526	$-627,790	$-448,167
Cash Flow From Continuing Operating Activities	$-8,925,777	$-733,526	$-627,790	$-448,167
Operating Gains Losses	$-77,523	-	-	-
Investing Activities
Capital Expenditure	$-57,333	-	-	-
Investing Cash Flow	$-10,060,351	$0	$0	$0
Cash Flow From Continuing Investing Activities	$-10,060,351	$0	-	-
Net Other Investing Changes	$-8,003,018	-	-	-
Financing Activities
Issuance Of Capital Stock	$11,629,727	$0	$1,055,000	$0
Financing Cash Flow	$20,619,327	$326,500	$1,032,100	$282,900
Cash Flow From Continuing Financing Activities	$20,619,327	$326,500	$1,032,100	$282,900
Net Other Financing Charges	$-1,260,500	$76,500	$-22,900	$22,900
Net Common Stock Issuance	$11,629,727	$0	$1,055,000	$0
Common Stock Issuance	$11,629,727	$0	$1,055,000	$0
Other
Issuance Of Debt	$10,250,100	$250,000	$0	$260,000
Interest Paid Supplemental Data	$0	$0	-	-
Income Tax Paid Supplemental Data	$0	$0	-	-
End Cash Position	$9,636,655	$3,455	$410,481	$6,171
Other Cash Adjustment Outside Changein Cash	$8,000,000	$0	-	-
Beginning Cash Position	$3,455	$410,481	$6,171	$171,438
Changes In Cash	$1,633,200	$-407,026	$404,310	$-165,267
Net Issuance Payments Of Debt	$10,250,100	$250,000	$0	$260,000
Net Long Term Debt Issuance	$10,250,100	$250,000	-	$0
Long Term Debt Issuance	$10,250,100	$250,000	-	$0
Net Investment Purchase And Sale	$-2,000,000	$0	-	-
Purchase Of Investment	$-2,000,000	$0	-	-
Net PPE Purchase And Sale	$-57,333	$0	-	-
Purchase Of PPE	$-57,333	$0	-	-
Change In Working Capital	$-2,821,288	$538,745	$41,842	$-2,180
Change In Payables And Accrued Expense	$-408,201	$536,752	$53,436	$-2,911
Change In Prepaid Assets	$-2,413,087	$1,993	$-11,594	$731
Other Non Cash Items	$2,712,497	$117,719	$38,069	$29,137
Stock Based Compensation	$3,265,806	$0	$69,993	$193,542
Unrealized Gain Loss On Investment Securities	$-6,009,838	$0	-	-
Depreciation Amortization Depletion	$5,706	$0	-	-
Depreciation And Amortization	$5,706	$0	-	-
Depreciation	$5,706	$0	-	-
Gain Loss On Investment Securities	$-77,523	-	-	-
Net Income From Continuing Operations	$-6,001,137	$-1,389,990	$-777,694	$-668,666
Net Short Term Debt Issuance	-	$250,000	$0	$260,000
Short Term Debt Issuance	-	$250,000	$0	$260,000

Fetched: 2026-06-05